Danish Pharmacovigilance Update 19 December 2013
17 February 2014
In this issue of Danish Pharmacovigilance Update:
News from the EU
- Restrictions on the use of metoclopramide (Primperan® etc.) for the treatment of nausea and vomiting
- Letters of safety information sent to doctors
News from the Danish Health and Medicines Authority
- Patients with mechanical heart valves should not be treated with the new oral anticoagulants Pradaxa®, Xarelto® and Eliquis®
- Stricter reporting requirements for suspected adverse reactions following vaccination with Infanrix hexa®
- Childhood vaccinations and reported suspected adverse reactions during the first half of 2013
- Desmopressin and hyponatraemia
- The Danish Health and Medicines Authority's analysis of melatonin users under the age of 25
Short news
- New opportunity to report adverse reactions from dietary supplements to the Danish Veterinary and Food Administration
- Clarification to the article 'Bisphosphonates/denosumab and the risk of osteonecrosis of the jaw' in Danish Pharmacovigilance Update, 28 November 2013